Seattle biotech AltPep closes $23M funding round for Alzheimer’s research
January 19, 2021 at 17:54 PM EST
Matrix Capital Management of Waltham, Massachusetts, led the round. AltPep's CEO says the funding will further the company's preclinical therapeutic program.
